Neoadjuvant Dupilumab and Toripalimab in MSS CRC Subjects With Resectable Liver Metastases

Name: Neoadjuvant Dupilumab and Toripalimab in MSS CRC Subjects With Resectable Liver Metastases
License: Public Domain

Dan Feng

ClinicalTrials.gov · Datasets · License: Public Domain

metastatic colorectal cancer, liver metastases

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Record · ID 290987
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.